(Q42949209)

English

Incidence and possible risk factors for clinical upper gastrointestinal events in patients taking selective cyclooxygenase-2 inhibitors: A prospective, observational, cohort study in Taiwan

scientific article published on July 1, 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

Incidence and possible risk factors for clinical upper gastrointestinal events in patients taking selective cyclooxygenase-2 inhibitors: A prospective, observational, cohort study in Taiwan (English)

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

author name string

Kuo-Wei Hsiang

1

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

Tseng-Shing Chen

2

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

Hsiao-Yi Lin

3

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

Jiing-Chyuan Luo

4

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

Ching-Liang Lu

5

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

Han-Chieh Lin

6

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

Kuei-Chuan Lee

7

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

Full-Young Chang

8

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

Shou-Dong Lee

9

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 July 2010

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

full work available at URL

https://api.elsevier.com/content/article/PII:S0149291810002328?httpAccept=text/xml

1 reference

10.1016/J.CLINTHERA.2010.07.005

https://api.crossref.org/works/10.1016/J.CLINTHERA.2010.07.005

15 June 2024

https://api.elsevier.com/content/article/PII:S0149291810002328?httpAccept=text/plain

1 reference

10.1016/J.CLINTHERA.2010.07.005

https://api.crossref.org/works/10.1016/J.CLINTHERA.2010.07.005

15 June 2024

Clinical Therapeutics

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

32

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

7

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

1294-1303

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

Update on guidelines for the treatment of chronic musculoskeletal pain

1

1 reference

10.1016/J.CLINTHERA.2010.07.005

https://api.crossref.org/works/10.1016/J.CLINTHERA.2010.07.005

15 June 2024

OARSI recommendations for the management of hip and knee osteoarthritis, Part II: OARSI evidence-based, expert consensus guidelines

2

1 reference

10.1016/J.CLINTHERA.2010.07.005

https://api.crossref.org/works/10.1016/J.CLINTHERA.2010.07.005

15 June 2024

Gastroprotective drugs in Australia: utilization patterns between 1997 and 2006 in relation to NSAID prescribing

3

1 reference

10.1016/J.CLINTHERA.2010.07.005

https://api.crossref.org/works/10.1016/J.CLINTHERA.2010.07.005

15 June 2024

Acute NSAID-related transmural duodenitis and extensive duodenal ulceration

4

1 reference

10.1016/J.CLINTHERA.2010.07.005

https://api.crossref.org/works/10.1016/J.CLINTHERA.2010.07.005

15 June 2024

Risk for Serious Gastrointestinal Complications Related to Use of Nonsteroidal Anti-inflammatory Drugs

5

1 reference

10.1016/J.CLINTHERA.2010.07.005

https://api.crossref.org/works/10.1016/J.CLINTHERA.2010.07.005

15 June 2024

Review article: prevention of non-steroidal anti-inflammatory drug gastrointestinal complications--review and recommendations based on risk assessment

6

1 reference

10.1016/J.CLINTHERA.2010.07.005

https://api.crossref.org/works/10.1016/J.CLINTHERA.2010.07.005

15 June 2024

Celecoxib versus diclofenac in long-term management of rheumatoid arthritis: randomised double-blind comparison.

7

1 reference

10.1016/J.CLINTHERA.2010.07.005

https://api.crossref.org/works/10.1016/J.CLINTHERA.2010.07.005

15 June 2024

Comparison of the effect of rofecoxib (a cyclooxygenase 2 inhibitor), ibuprofen, and placebo on the gastroduodenal mucosa of patients with osteoarthritis: a randomized, double-blind, placebo-controlled trial. The Rofecoxib Osteoarthritis Endoscopy M

8

1 reference

10.1016/J.CLINTHERA.2010.07.005

https://api.crossref.org/works/10.1016/J.CLINTHERA.2010.07.005

15 June 2024

Gastrointestinal safety of cyclooxygenase-2 inhibitors: a Cochrane Collaboration systematic review

9

1 reference

10.1016/J.CLINTHERA.2010.07.005

https://api.crossref.org/works/10.1016/J.CLINTHERA.2010.07.005

15 June 2024

Celecoxib versus diclofenac and omeprazole in reducing the risk of recurrent ulcer bleeding in patients with arthritis

10

1 reference

10.1016/J.CLINTHERA.2010.07.005

https://api.crossref.org/works/10.1016/J.CLINTHERA.2010.07.005

15 June 2024

Celecoxib versus diclofenac plus omeprazole in high-risk arthritis patients: results of a randomized double-blind trial.

11

1 reference

10.1016/J.CLINTHERA.2010.07.005

https://api.crossref.org/works/10.1016/J.CLINTHERA.2010.07.005

15 June 2024

Celecoxib compared with lansoprazole and naproxen to prevent gastrointestinal ulcer complications

12

1 reference

10.1016/J.CLINTHERA.2010.07.005

https://api.crossref.org/works/10.1016/J.CLINTHERA.2010.07.005

15 June 2024

Seven-day intravenous low-dose omeprazole infusion reduces peptic ulcer rebleeding for patients with comorbidities.

13

1 reference

10.1016/J.CLINTHERA.2010.07.005

https://api.crossref.org/works/10.1016/J.CLINTHERA.2010.07.005

15 June 2024

The potential risk factors leading to peptic ulcer formation in autoimmune disease patients receiving corticosteroid treatment

14

1 reference

10.1016/J.CLINTHERA.2010.07.005

https://api.crossref.org/works/10.1016/J.CLINTHERA.2010.07.005

15 June 2024

Gastric mucosal injury in systemic lupus erythematosus patients receiving pulse methylprednisolone therapy

15

1 reference

10.1016/J.CLINTHERA.2010.07.005

https://api.crossref.org/works/10.1016/J.CLINTHERA.2010.07.005

15 June 2024

Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group

16

1 reference

10.1016/J.CLINTHERA.2010.07.005

https://api.crossref.org/works/10.1016/J.CLINTHERA.2010.07.005

15 June 2024

Occurrence of peptic ulcer disease in connective tissue disease patients associated with xerostomia

17

1 reference

10.1016/J.CLINTHERA.2010.07.005

https://api.crossref.org/works/10.1016/J.CLINTHERA.2010.07.005

15 June 2024

Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: A randomized controlled trial. Celecoxib Long-term Arthritis Safety Study

18

1 reference

10.1016/J.CLINTHERA.2010.07.005

https://api.crossref.org/works/10.1016/J.CLINTHERA.2010.07.005

15 June 2024

Management of patients on nonsteroidal anti-inflammatory drugs: a clinical practice recommendation from the First International Working Party on Gastrointestinal and Cardiovascular Effects of Nonsteroidal Anti-inflammatory Drugs and Anti-platelet Ag

20

1 reference

10.1016/J.CLINTHERA.2010.07.005

https://api.crossref.org/works/10.1016/J.CLINTHERA.2010.07.005

15 June 2024

Omeprazole compared with misoprostol for ulcers associated with nonsteroidal antiinflammatory drugs. Omeprazole versus Misoprostol for NSAID-induced Ulcer Management (OMNIUM) Study Group.

21

1 reference

10.1016/J.CLINTHERA.2010.07.005

https://api.crossref.org/works/10.1016/J.CLINTHERA.2010.07.005

15 June 2024

A comparison of omeprazole with ranitidine for ulcers associated with nonsteroidal antiinflammatory drugs. Acid Suppression Trial: Ranitidine versus Omeprazole for NSAID-associated Ulcer Treatment (ASTRONAUT) Study Group

22

1 reference

10.1016/J.CLINTHERA.2010.07.005

https://api.crossref.org/works/10.1016/J.CLINTHERA.2010.07.005

15 June 2024

Meta-analysis: role of Helicobacter pylori eradication in the prevention of peptic ulcer in NSAID users

23

1 reference

10.1016/J.CLINTHERA.2010.07.005

https://api.crossref.org/works/10.1016/J.CLINTHERA.2010.07.005

15 June 2024

Identifiers

10.1016/J.CLINTHERA.2010.07.005

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42949209&oldid=2180029110"